Page 31 - Michael Erman News Today

By Nancy Lapid (Reuters) - The number of U.S. women who died within a year after pregnancy more than doubled between 1999 and 2019, with the highest d...

By Nancy Lapid (Reuters) - The number of U.S. women who died within a year after pregnancy more than doubled between 1999 and 2019, with the highest d...

By Nancy Lapid (Reuters) - The number of U.S. women who died within a year after pregnancy more than doubled between 1999 and 2019, with the highest d...

By Nancy Lapid (Reuters) - The number of U.S. women who died within a year after pregnancy more than doubled between 1999 and 2019, with the highest d...

By Nancy Lapid (Reuters) - The number of U.S. women who died within a year after pregnancy more than doubled between 1999 and 2019, with the highest d...

(Reuters) -The U.S. government on Friday released its revised guidance for its Medicare drug price negotiation program, saying it will allow drug companies to publicly discuss the negotiation at their discretion. In September, the U.S. Centers for Medicare and Medicaid Services (CMS) will select 10 of the Medicare program's costliest prescription medicines and negotiate price cuts to go into effect for 2026. Two top drugmakers, the U.S. Chamber of Commerce and the leading industry lobby h...

CDC Director Rochelle Walensky endorsed agency advisers' recommendation last week that adults aged 60 or older get the shots, but stopped short of saying all of that population should get one of the vaccines. The vaccines are the first approved to prevent RSV, which causes around 14,000 deaths in adults aged 65 and older in the U.S. annually, according to government estimates.

(Reuters) -The director of the U.S. Centers for Disease Control and Prevention on Thursday signed off on the use of new vaccines from Pfizer and GSK to ...

The director of the U.S. Centers for Disease Control and Prevention on Thursday signed off on the use of new vaccines from Pfizer and GSK to prevent severe respiratory syncytial virus infections in...

GSK agreed to settle a U.S. lawsuit alleging its discontinued heartburn drug Zantac caused cancer, the British drugmaker said on Friday, preventing the first such case from going to trial next month. The company said it had reached a confidential deal with Californian resident James Goetz who says he developed bladder cancer from taking the drug.